The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 04, 2023

Filed:

Apr. 08, 2021
Applicants:

Eligo Bioscience, Paris, FR;

Kantonsspital St.gallen, St.Gallen, CH;

Inventors:

Xavier Duportet, Paris, FR;

Cristina del Carmen Gil-Cruz, St. Gallen, CH;

Christian Ivan Pérez-Shibayama, St. Gallen, CH;

Burkhard Ludewig, St. Gallen, CH;

Assignees:

Eligo Bioscience, Paris, FR;

Kantonsspital St.Gallen, St.Gallen, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); A01N 63/00 (2020.01); C07H 21/04 (2006.01); A61K 35/76 (2015.01); C12N 9/22 (2006.01); A61K 31/7036 (2006.01); A61K 31/505 (2006.01); A61K 38/14 (2006.01); A61K 31/4164 (2006.01); A61K 31/635 (2006.01); A61K 31/7056 (2006.01);
U.S. Cl.
CPC ...
A61K 35/76 (2013.01); A61K 31/4164 (2013.01); A61K 31/505 (2013.01); A61K 31/635 (2013.01); A61K 31/7036 (2013.01); A61K 31/7056 (2013.01); A61K 38/14 (2013.01); C12N 9/22 (2013.01); A61K 48/005 (2013.01); C12N 2310/20 (2017.05);
Abstract

The invention relates to methods, kits and compositions for reducing the level of or eliminatingin situ. The invention encompasses methods of preventing myocarditis, treating myocarditis or dilated cardiomyopathy, or limiting progression of myocarditis toward dilated cardiomyopathy in a subject in need thereof, comprising reducing the amount ofsp. in the subject. The invention further encompasses methods of diagnosis of a subject as having myocarditis or dilated cardiomyopathy. The invention also encompasses compositions preventing myocarditis, treating myocarditis or dilated cardiomyopathy, or limiting progression of myocarditis toward dilated cardiomyopathy in a subject in need thereof.


Find Patent Forward Citations

Loading…